Cellect Biotechnology logo

APOP - Cellect Biotechnology News Story

$3.17 0.0  0.3%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £5.28m
Enterprise Value £805k
Revenue £n/a
Position in Universe 6152nd / 6630

BUZZ-Cellect Biotechnology: Gains on new patent allowance in Canada

Mon 27th April, 2020 4:40pm
** U.S. shares of Israel-based stem cell therapy developer
 APOP.O  rise ~4% to $2.50
    ** Canadian Intellectual Property Office grants APOP patent
for a device and kit adapted to select cells resistant to
receptor-mediated apoptosis, which is process of programmed cell
death  urn:newsml:reuters.com:*:nPn2lq4ZSa
    ** Device can help selection of stem cells from any given
tissue, and aims to improve variety of stem cell-based therapies
- APOP
    ** Including session's gain, shares have risen ~13% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.